IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Ranbaxy allocated land at Kulim for Malaysian pharma plant

August 8, 2013 | Natasha Alperowicz

Ranbaxy Laboratories (Gurgaon, India) announced today that its Malaysian subsidiary Ranbaxy Malaysia has been allocated a site for a previously announced greenfield pharmaceuticals manufacturing facility in Malaysia. Ranbaxy Malaysia, a joint venture between Ranbaxy Laboratories and Malaysian shareholders, will build the plant within the Kulim Hi Tech Park (KHTP) at Kulim in the state of Kedah.   The agreement with KHTP, a wholly owned state agency, was signed by T. Jeyabalan Thangarajah, managing director of Ranbaxy Malaysia and Tuan Haji Muhammad Sobri...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa